Search results
Novartis, Roche unit and others face Italy antitrust probe over eye drug
Reuters via AOL· 1 day agoROME (Reuters) -Italy's antitrust regulator said on Thursday it had launched an investigation into...
US judge orders probe of Novartis $30 mln settlement claims process
Reuters· 21 hours agoA federal judge has ordered a probe of the claims distribution process in a $30 million settlement...
Earnings call: Novartis outlines strong forecast for Scemblix in CML treatment By Investing.com
Investing.com· 2 days agoNovartis has projected robust sales for its new chronic myeloid leukemia (CML) treatment, Scemblix,...
Italy Probes European Pharma Giants Novartis, Roche Over Eye Drug Competition Allegations - Novartis...
Benzinga· 20 hours agoItaly’s antitrust regulator has initiated an investigation into several pharmaceutical giants,...
Why Novartis (NVS) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 24 hours agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Novartis, Roche, Biogen and Samsung Bioepis in Italy Eye-Medicine Probe
Morningstar· 1 day agoItaly's competition watchdog is investigating four pharmaceutical companies over what it called coordination of their commercial strategies, allegedly delaying access to a biosimilar eye-disease ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 14 hours agoAt BIO 2024 International Convention, the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding (MoU) with
Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
Zacks via Yahoo Finance· 7 days agoNovartis NVS announced new long-term efficacy and safety data from the late-stage studies REMIX-1...
Novartis Sues to Block Maryland's New Drug Discount Law - Novartis (NYSE:NVS)
Benzinga· 7 days agoNovartis AG NVS has reportedly filed a lawsuit to block a Maryland law requiring drugmakers to offer...
Novartis' Oral Drug For Chronic Skin Disease Candidate Shows Efficacy, Long-term Safety - Novartis...
Benzinga· 7 days agoOn Friday, Novartis AG NVS released new data that confirm the long-term efficacy and safety of...